Context The role of surgery in metastatic bladder cancer (BCa) is unclear. Objective In this
collaborative review article, we reviewed the contemporary literature on the surgical …

Context Invasive bladder cancer is a frequently occurring disease with a high mortality rate
despite optimal treatment. The European Association of Urology (EAU) Muscle-invasive and …

Background: Cisplatin-based combination chemotherapy is standard treatment for
metastatic urothelial carcinoma; however, the vast majority of patients experience disease …

Background We aimed to evaluate the prognostic value of site-specific metastases in
patients with metastatic bladder cancer and analyze the roles that surgeries play in the …

The European Association of Urology (EAU) Guidelines Panel for Muscle-invasive and
Metastatic Bladder Cancer (MIBC) has prepared these guidelines to help urologists assess …

Simple Summary Radiotherapy with curative intent in the treatment of metastatic
malignancies has shown promising results in several types of primary tumors but experience …

Purpose We determined prognostic factors associated with prolonged survival after
metastasectomy for urothelial carcinoma. Materials and Methods A total of 42 patients who …

Aims Bladder cancer represents the most common type of urothelial carcinoma, with a
median overall survival of 12.5–15 months in the case of metastatic disease. We evaluated …

In patients with metastatic deposits amenable to surgical resection, metastasectomy stands
as a promising avenue. Metastatic-directed radiotherapy has demonstrated local control and …

Background The purpose of the study was to evaluate the efficacy of metastasectomy for
urinary tract carcinoma (UTC) and to determine prognostic factors that affect survival …